NCT07059819View on ClinicalTrials.gov

Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection

NAEnrolling by invitationINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

November 2, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions
Cervical Intraepithelial Neoplasia (CIN)Human Papillovirus
Interventions
DEVICE

Local hyperthermia device

Local hyperthermia at 44℃ for 30 mins on cervical region, at days of 1,2,3 and 17, 18.

Trial Locations (1)

110001

the First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

First Hospital of China Medical University

OTHER